Novartis AG ADR（NVS）株価

Novartis AG ADR（NVS）はNYSEに上場しているHealthcare · Drug Manufacturers - Generalの企業です。 現在値 $140.93 (-0.05%)、時価総額 $285.28B、PER（株価収益率） 21.45、52週 安値・高値 $110.71 ~ $168.62。

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Revolade to treat immune thrombocytopenia (ITP), thrombocytopenia, and patients with severe aplastic anemia (SAA); Tafinlar+Mekinist, an oral combination therapy to treat patients with

主要指標

• 現在値: $140.93 (-0.05%)
• 時価総額: $285.28B
• PER（株価収益率）: 21.45
• 52週 安値・高値: $110.71 ~ $168.62
• セクター: Healthcare
• 業種: Drug Manufacturers - General
• 取引所: NYSE

Novartis AG ADRの財務諸表、目標株価、機関投資家（13F）の保有状況、関連ニュースは BlackAll Trade でリアルタイムに確認できます。

Novartis AG ADR 財務サマリー

アナリスト予想

• アナリスト評価コンセンサス: 2.8462

主要財務比率・収益性・成長性

• PBR（株価純資産倍率）: 7.24
• 純利益率: 0.24%
• 営業利益率: 0.30%
• 配当利回り: 0.03%

Novartis AG ADR 投資家ディスカッション

最近の投稿 7件・強気 6・弱気 0・中立 1。

• [強気] NVS 파이프라인 견조하고 Entresto랑 CAR-T가 장기 성장 동력 될 듯
• [強気] NVS 파이프라인 견조하고 Entresto랑 CAR-T가 장기 성장 동력 될 듯 ㅋㅋ
• [中立] NVS 파이프라인 견조해 보이네. 근데 Entresto 특허 이슈랑 CAR-T 경쟁 심화는 리스크로 작용할 수도 있음
• [強気] NVS 파이프라인 견조하고 Entresto랑 CAR-T가 장기 성장 동력 될 듯 ㅋㅋ
• [強気] NVS 파이프라인 견조하고 Entresto와 CAR-T가 장기 성장 동력 될 듯

よくある質問